
Expedition Therapeutics Secures Oversubscribed $115 Million Series B to Advance Next-Generation COPD Therapy
Expedition Therapeutics Raises Oversubscribed $115 Million Series B Financing and Advances EXPD-101 into Phase 2 Clinical Trial for COPD Expedition Therapeutics, a clinical-stage biotechnology company focused on developing innovative oral…

Synthekine Appoints Biotech Veteran Susan M. Molineaux, Ph.D., as Chief Executive Officer
Synthekine Appoints Biotechnology Veteran Dr. Susan M. Molineaux as CEO to Lead Next Phase of Oncology Drug Development Synthekine, Inc., a clinical-stage biotechnology company focused on developing precision cytokine therapeutics…

ZAP Surgical Expands China Footprint with Eighth ZAP-X System Installation
ZAP Surgical Expands Presence in China with New ZAP-X Radiosurgery Installation at Changchun Tumor Hospital ZAP Surgical Systems, Inc., a global innovator in non-invasive robotic brain surgery technologies, has announced…

Twist Bioscience Announces Proposed $250 Million Public Offering of Common Stock
Twist Bioscience Launches $250 Million Public Stock Offering to Support R&D, Manufacturing Expansion, and Long-Term Growth Twist Bioscience Corporation (Nasdaq: TWST), a biotechnology company recognized for its synthetic DNA technology…

Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher to Accelerate Drug Development
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher to Accelerate Plozasiran Approval for Severe Hypertriglyceridemia Arrowhead Pharmaceuticals, Inc. has announced that it has entered into an agreement with an undisclosed third…

LabPMM® Launches Global KMT2A MRD Testing Service to Advance Menin Inhibitor Development
LabPMM Launches Global KMT2A MRD Testing Service to Support Precision Monitoring and Clinical Development in Acute Leukemia LabPMM®, a global reference laboratory and subsidiary of Invivoscribe®, has announced the worldwide…

FUJIFILM Biotechnologies Announces Leadership Transition to Advance Operational Excellence
FUJIFILM Biotechnologies Appoints Maja Pedersen as President to Lead Next Phase of Global Growth and Operational Excellence FUJIFILM Biotechnologies has announced a significant leadership transition designed to support the company’s…

Mosaic Therapeutics Appoints Dr. Allison Jeynes as Board Chair
Mosaic Therapeutics Strengthens Leadership with Appointment of Dr. Allison Jeynes as Board Chair to Drive Clinical Growth Mosaic Therapeutics, a biotechnology company focused on developing innovative targeted combination therapies for…

Niagen Bioscience Partners with Evotec to Advance NB4168 Development
Niagen Bioscience Partners with Evotec to Advance NB4168 Development for Rare Genetic Disease Niagen Bioscience, Inc. (NASDAQ: NAGE), a biotechnology company recognized for its leadership in NAD+ (nicotinamide adenine dinucleotide)…

Inocras Raises $31 Million in Oversubscribed Series B-3 Financing
Inocras Raises $31 Million to Accelerate U.S. Expansion of Whole-Genome Sequencing Platform for Precision Oncology Inocras Inc., a bioinformatics-driven precision medicine company specializing in whole-genome sequencing (WGS) and advanced genomic…

Spruce Biosciences Appoints Dr. Jessica Cohen Pfeffer as VP of Clinical Development
Spruce Biosciences Appoints Dr. Jessica Cohen Pfeffer as Vice President of Clinical Development to Advance Rare Neurological Disease Pipeline Spruce Biosciences, Inc., a late-stage biopharmaceutical company dedicated to developing and…

Family Heart Foundation CEO Katherine Wilemon Receives ASPC Honorary Fellow Award
Family Heart Foundation Founder Katherine Wilemon Receives ASPC 2026 Honorary Fellow Award for Advancing Cardiovascular Disease Prevention The Family Heart Foundation, a leading nonprofit organization dedicated to research, education, advocacy,…


